Unified Business No.

54170142

Listing

Emerging stock (TPEx) (359) 6586

Founded

2013-03-08

Paid-in capital

NT$ 2,140,105,000

Phone

02-26558059

Website

https://www.chopharma.com/

Exporter

Yes — registered with the Trade Administration

Annual revenue band

< NT$20M

Ownership

Group subsidiary / corporate-held · Chung Yang Yen Chiu Yuan

Representative tenure

In office since 2018-01 (8 yrs); last handover 2018-01 (same surname)

Growth & profitability

Revenue 2026-09 YoY 0.0%, year-to-date +30.8%
Gross margin 59.4%, operating margin -11417.1%, net margin -9752.6% (2026-Q2 YTD)

Certifications 1

• FDA (53)Self-reported

Processes & materials 1

• Testing & inspection (1,056) · Assembly & inspectionSelf-reported

Patents 6

• 2025 Antibody for enriching cells
• 2025 Immune composition comprising antigen and glyco-engineered antibody thereof
• 2025 Fusion protein for remodeling antibody glycoform

Similar companies 10

• FORESEE PHARMACEUTICALS CO., LTD. Listed (TPEx) NT$100–500M
  Shared: Natural & engineering science R&D services, Western pharmaceutical retail
• TAIWANJ PHARMACEUTICALS, CO., LTD. Emerging stock (TPEx) NT$20–100M estimated
  Shared: Natural & engineering science R&D services, Western pharmaceutical retail
• TRIPARTITE THERAPEUTICS INC. Emerging stock (TPEx) NT$0.5–1B estimated
  Shared: Natural & engineering science R&D services
• PHARMAENGINE, INC. Listed (TPEx) NT$1–5B
  Shared: FDA, Western pharmaceutical retail
• TLC BioSciences Corp. Emerging stock (TPEx) NT$20–100M
  Shared: FDA
• INPSYTECH, INC. Emerging stock (TPEx) NT$0.5–1B
  Shared: Natural & engineering science R&D services
• Yung Sheng Biotech Co., Ltd. Listed (TWSE) NT$100–500M
  Shared: FDA
• Jung Huei Chi Tuan Co., Ltd. Listed (TWSE) NT$1–5B
  Shared: Testing & inspection
• TPK Holding Co., Ltd. Listed (TWSE) ≥ NT$5B
  Shared: Testing & inspection
• Ho Fu Yi Liao Holdings Co., Ltd. Listed (TPEx) NT$0.5–1B estimated
  Shared: Testing & inspection

Open in advanced filters →